We serve Chemical Name:phenanthren-2-ylmethanol CAS:2606-54-4 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:phenanthren-2-ylmethanol
CAS.NO:2606-54-4
Synonyms:2-Hydroxymethyl-phenanthren;2-phenanthrenylmethanol;2-Phenanthrenemethanol;2-Phenanthryl-carbinol;2-hydroxymethylphenanthrene;2-phenanthrylmethanol
Molecular Formula:C15H12O
Molecular Weight:208.25500
HS Code:2906299090
Physical and Chemical Properties:
Melting point:N/A
Boiling point:423.386ºC at 760 mmHg
Density:1.214 g/cm3
Index of Refraction:1.729
PSA:20.23000
Exact Mass:208.08900
LogP:3.48530
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:
Contact us for information like 2-Hydroxymethyl-phenanthren chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,2-phenanthrylmethanol physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,2-Phenanthrenemethanol Use and application,2-hydroxymethylphenanthrene technical grade,usp/ep/jp grade.
Related News: Novavax, a Maryland biotechnology company that has struggled mightily with delays in developing its coronavirus vaccine, announced Monday that its two-shot regimen was over 90% effective overall in a trial that unfolded even as more contagious variants emerged. phenanthren-2-ylmethanol manufacturer A GSK spokesman said it was not yet clear by when ViiV would be able to address the FDA��s concerns. phenanthren-2-ylmethanol supplier In that group, the vaccine slowed brain decline by around 30% in two different clinical and functional tests, Novak said. phenanthren-2-ylmethanol vendor Novavax, a Maryland biotechnology company that has struggled mightily with delays in developing its coronavirus vaccine, announced Monday that its two-shot regimen was over 90% effective overall in a trial that unfolded even as more contagious variants emerged. phenanthren-2-ylmethanol factory Under the terms of this agreement, Inceptua will support Onconova through the pre-approval provision of intravenous rigosertib initially into a number of countries including: Australia, Denmark, Finland, France, Ireland, Italy, the Netherlands, Portugal, South Africa, Spain, and the UK.
